A second example of anti-Es^a, an antibody to a high-incidence Cromer antigen

1.Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988;167:1993–8.10.1084/jem.167.6.199321896702455016Search in Google Scholar

2.Spring FA, Judson PA, Daniels GL, Parsons SF, Mallinson G, Anstee DJ. A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 1987;62:307–13.Search in Google Scholar

3.Petty AC, Daniels GL, Anstee DJ, Tippett P. Use of the MAIEA technique to confirm the relationship between the Cromer antigens and decay-accelerating factor and to assign provisionally antigens to the short-consensus repeats. Vox Sang 1993;65:309–15.Search in Google Scholar

4.Lublin DM, Mallinson G, Poole J, et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994;84:1276–82.10.1182/blood.V84.4.1276.1276Search in Google Scholar

5.Telen MJ, Rao N, Udani M, Thompson ES, Kaufman RM, Lublin DM. Molecular mapping of the Cromer blood group Cr^a and Tc^a epitopes of decay-accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994;84: 3205-11.10.1182/blood.V84.9.3205.3205Search in Google Scholar

6.Daniels G. Cromer-related antigens: blood group determinants on decay-accelerating factor. Vox Sang 1989;56:205–11.10.1111/j.1423-0410.1989.tb02030.x2474898Search in Google Scholar

7.Stony JR. Serology and genetics of the Cromer blood group system. In: Moulds JM, Laird-Fryer B, eds. Blood groups: Ch/Rg, Kn/McC/Yk, Cromer. Bethesda, MD: American Association of Blood Banks, 1992:31–43.Search in Google Scholar

8.Reid ME, Green CA, Hoffer J, Øyen R. Effect of pronase on high-incidence blood group antigens and the prevalence of antibodies to pronase-treated erythrocytes. (In press, Immunohematology 1996).10.21307/immunohematology-2019-767Search in Google Scholar

9.Rosse WF. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood 1990;75:1595–601.10.1182/blood.V75.8.1595.1595Search in Google Scholar

10.Telen MJ, Rosse WF, Parker CJ, Moulds MK, MouldsJJ. Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins. Blood 1990;75:1404–7.10.1182/blood.V75.7.1404.1404Search in Google Scholar

11.Daniels GL, Okubo Y, Yamaguchi H, Seno T, Ikuta M. UMC, another Cromer-related blood group antigen. Transfusion 1989;29:794–7.10.1046/j.1537-2995.1989.29990070184.x2480010Search in Google Scholar

12.Tregellas WM. Description of a new blood group antigen, Es^a. Abstracts of the 18th Congress of the International Society of Blood Transfusion, Basel, Karger, 1984:163.Search in Google Scholar

13.Daniels GL. Characteristics of Cromer-related antibodies (abstract). Transfusion 1983;23:410.Search in Google Scholar

14.American Red Cross. Immunohematology methods and procedures. Rockville, MD: American Red Cross National Reference Laboratory, 1993.Search in Google Scholar

15.Postoway N, Garratty G. Standardization of IgG subclass antiserums for use with sensitized red cells. Transfusion 1983;23:398–400.10.1046/j.1537-2995.1983.23584018719.x6623608Search in Google Scholar

16.Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.10.1046/j.1537-2995.1987.27688071692.x3686653Search in Google Scholar

17.Reid ME, Chandrasekaran V, Sausais L, Pierre J, Bullock R. Disappearance of antibodies to Cromer blood group system antigens during mid-pregnancy. Vox Sang (in press).Search in Google Scholar

18.Mourant AE, Kopec AC, Domaniewska-Sobczak K. The distribution of the human blood groups and other polymorphisms. London: Oxford University Press, 1976:124.Search in Google Scholar